No Data
No Data
Kim Dawei | Frequent mergers and acquisitions, poor market capitalization, synthetic organisms, vitamins, NMN, and health products. Who will save them from their difficult performance?
Can performance be reversed again?
Xiamen Kingdomway Group's (SZSE:002626) Earnings Trajectory Could Turn Positive as the Stock Soars 11% This Past Week
It is doubtless a positive to see that the Xiamen Kingdomway Group Company (SZSE:002626) share price has gained some 32% in the last three months. But that is small recompense for the exasperating
Jin Dawei (002626.SZ): Net profit of 707.938 million yuan in the first quarter decreased by 18.58% year-on-year
On April 29, Ge Longhui (002626.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 743 million yuan, down 5.99% year on year; net profit attributable to shareholders of listed companies was 707.938 million yuan, down 18.58% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 697.157 million yuan, down 15.35% year on year; basic earnings per share were 0.12 yuan.
Jin Dawei (002626.SZ): “A method for preparing nicotinamide adenine dinucleotide” obtained an invention patent
Gelonghui, April 11 | Jin Dawei (002626.SZ) announced that the company's holding subsidiary Jiangsu Chengxin Pharmaceutical Co., Ltd., the company and its wholly-owned subsidiary Inner Mongolia Jindaway Pharmaceutical Co., Ltd., and its wholly-owned subsidiary Jindaway Biotechnology (Jiangsu) Co., Ltd. recently each received an invention patent certificate issued by the State Intellectual Property Office, which is a preparation method for nicotinamide adenine dinucleotide.
Calculating The Intrinsic Value Of Xiamen Kingdomway Group Company (SZSE:002626)
Key Insights Xiamen Kingdomway Group's estimated fair value is CN¥18.31 based on 2 Stage Free Cash Flow to Equity With CN¥14.95 share price, Xiamen Kingdomway Group appears to be trading close to it
Jindaway (002626.SZ): Jindaway vitamins gradually resume work and resume production
On April 1, Gelonghui (002626.SZ) announced that the company's wholly-owned subsidiary, Xiamen Jindawei Vitamin Co., Ltd. (Jindawei Vitamins for short), has gradually resumed work and resumed production. At around 9 a.m. on January 11, 2024, an explosion occurred in the Jindaway Vitamin sewage treatment tank space. After the accident, production of Jindaway Vitamins was discontinued. Currently, Jindawei Vitamin has gradually resumed work and production.
No Data